XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.3

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Calculations of Earnings Per Share

The calculations of earnings per share are as follows:

			Three Months Ended September 30,												Nine Months Ended September 30,
($ and shares in millions except per share amounts)			2024						2023						2024						2023
Net Income Attributable to Merck & Co., Inc.			$	3,157					$	4,745					$	13,374					$	1,591
Average common shares outstanding			2,534						2,537						2,534						2,538
Common shares issuable (1)			7						9						9						11
Average common shares outstanding assuming dilution			2,541						2,546						2,543						2,549
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders			$	1.25					$	1.87					$	5.28					$	0.63
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders			$	1.24					$	1.86					$	5.26					$	0.62

(1)    Issuable primarily under share-based compensation plans.

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration